Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients

Name	Symbol	Market	Type
Lyxor Index Fund-Lyxor Stoxx Europe 600 Pers& Hou Good UCITS ETF	BIT:PHG	Italy	Exchange Traded Fund

Lyxor Index Fund-Lyxor S... (BIT:PHG)
Historical Stock Chart

From Dec 2019 to Dec 2024

Click Here for more Lyxor Index Fund-Lyxor S... Charts.

CHICAGO, Nov. 29 /PRNewswire/ -- Royal Philips Electronics (NYSE:PHGNYSE: AEX:NYSE:PHI) today announced its response to an industry need by showing its portfolio of products designed to manage dose radiation at this year's 95th annual meeting of the Radiological Society of North America (RSNA) in Chicago. New this year from Philips are several advancements and upgrades focused on redefining imaging, managing dose radiation and streamlining workflow to expand upon clinical capabilities. Philips will also showcase the company's financing solutions for customers exploring radiology investments. (Logo: http://www.newscom.com/cgi-bin/prnh/20091129/NY17600LOGO ) Advancements in medical imaging are continuously opening new doors in early diagnosis and disease management. Despite the progress of this technology, both the radiology and patient communities have concerns regarding the potential risks of radiation dose. As healthcare guidelines continue to shift and more intense focus is directed to dose radiation risk and reduction, it is increasingly important radiologists have access to imaging systems that may limit exposure while upholding image quality and ease of use. "Hospitals are under intense pressure to deliver high-quality care while lowering costs and exceeding standards for patient safety," said Gene Saragnese, CEO, Imaging Systems, Philips Healthcare. "Philips is dedicated to supporting our customers with systems that drive value and technologies that help enable a reduction of radiation dose to patients and hospital staff, while maintaining exceptional image quality to aid in the diagnosis and treatment of patients." New solutions to redefine imaging and manage dose for patients and clinicians, alike iDose for Philips CT Philips is unveiling a new X-ray dose reduction technique, iDose. The newest addition to Philips' DoseWise suite of radiation management tools, iDose focuses on lowering X-ray dose while maintaining high image quality and fast reconstruction times. The iDose reconstruction technique, RapidView IR console, enables 20 times faster reconstruction than current hardware and lowers X-ray dose up to 80 percent while maintaining diagnostic image quality. As an ongoing commitment to streamlining workflow for radiologists, iDose was designed to provide the same look and feel of the original, higher-dose radiation images, so there's no additional training needed. iDose is available for new and installed base Brilliance iCT and 64-channel scanners with expected delivery in the second half of 2010. DoseAware For interventional radiologists, Philips will introduce DoseAware, the latest addition to Philips' DoseWise portfolio of solutions to help track X-ray exposure of patients and staff. DoseAware delivers real-time visualization, display and tracking of clinical staff X-ray dose to help healthcare professionals performing potentially lengthy interventional procedures manage their radiation exposure on the spot. EasyDiagnost Eleva A single fluoroscopy room is not cost-effective in today's environment with a shift of exams to other modalities. The combination of Philips' high-end digital vertical stand (or digital in-table detector) and the EasyDiagnost Eleva with ceiling suspension manages both high-quality digital radiography as well as fluoroscopy (DRF) applications, enabling users to perform gastro-intestinal work, as well as chest and skeletal exams, in just one room. In addition, the DRF design consists of various single features to help enable lower X-ray doses to be delivered, including pediatric fluoroscopy settings, Grid Controlled Fluoroscopy and dose measurement. This is especially relevant in the pediatric setting. The Eleva is easy to operate, fast and offers the ability to customize protocols and techniques for individual physician preferences. Based on open standards, the EasyDiagnost Eleva can seamlessly integrate into any hospital network. GEMINI TF PET/CT Showcasing Philips' newest innovation in oncology care, the Philips GEMINI TF PET/CT streamlines the processes involved in staging, planning, therapy and follow-up in oncology care. With Generation 3 Time-of-Flight technology, the GEMINI TF system is the company's fastest ever PET scanner, capturing data in less than 500 picoseconds, without compromising image quality or attention to dose radiation efficiency. Philips GEMINI TF is seeing increased traction for oncology diagnosis and follow-up. The U.S. Centers for Medicare and Medicaid Services (CMS) final decision expands coverage for Medicare patients for 11 cancer types and adds new coverage for initial treatment in seven other cancer indications. FDG-PET exams, such as those performed on the GEMINI TF, can be performed as part of the initial treatment strategy and to further guide subsequent treatment strategies. Philips GEMINI TF family will now play an even larger role in women's care due to the recent CMS decision to expand Medicare coverage for the reimbursement of exams for the initial staging of patients with biopsy-proven cervical cancer. BrightView XCT SPECT/CT Philips is showcasing new clinical images from the BrightView XCT. BrightView XCT using Astonish image reconstruction technology provides 50 percent better spatial resolution in cardiac SPECT studies compared to SPECT studies using filtered back projection. BrightView XCT helps enable low patient X-ray dose levels, high-resolution localization and high-quality attenuation correction with the potential for fewer artifacts and shorter exam times. Additionally, Philips will highlight new clinical evidence that Philips' Astonish algorithms for nuclear cardiology help clinicians improve their diagnostic accuracy and increase their diagnostic confidence. Allura Xper FD20 Release 7 For new and existing customers, the new release of the Allura Xper FD20 combines a full range of advanced interventional tools and seamless multi-modality cath lab integration. It also offers a balance between superb image quality and low X-ray dose during lengthy procedures. The system is upgradable, offering access to the latest clinical and service innovations as part of the lifetime Philips commitment. Following the upgrade, the Allura Xper system will have advanced tools to support image-guided procedures. The MR/CT Roadmap feature allows clinicians to synchronize live fluoroscopy with previously Acquired MRA/CTA datasets to help reduce contrast media use and X-ray dose compared to standard 2D or 3D navigation. Partnering for your success Philips Medical Capital Philips Medical Capital (PMC) provides financing tailored for the healthcare community. In today's weakened credit markets where borrowing money continues to be difficult, PMC stands apart, as a strong and stable finance company with money to lend. For healthcare providers concerned about careful cash flow management, expense monitoring or reducing financial leverage, PMC can help. Financing solutions are designed to address these and other pressing business concerns so providers can acquire the technology they need. PMC is a joint venture between Philips Healthcare and De Lage Landen, a division of Dutch-owned, AAA-rated Rabobank. Rabobank has ranked in the top ten of the 'world's safest banks' survey by Global Finance for the past ten consecutive years. Please find additional information on new products showcased at RSNA by visiting the Philips booth, #7725, located at McCormick Place, North Building, Hall B or visit http://www.philips.com/media. .About Royal Philips Electronics Royal Philips Electronics of the Netherlands (NYSE:PHGNYSE:AEX:NYSE:PHI) is a diversified Health and Well-being company, focused on improving people's lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of "sense and simplicity". Headquartered in the Netherlands, Philips employs more than 118,000 employees in more than 60 countries worldwide. With sales of $38 billion in 2008, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in flat TV, male shaving and grooming, portable entertainment and oral healthcare. News from Philips is located at http://www.philips.com/newscenter. http://www.newscom.com/cgi-bin/prnh/20091129/NY17600LOGO DATASOURCE: Philips Healthcare CONTACT: Steve Kelly, Philips Healthcare, +1-425-487-7479, ; Ian Race, Philips Healthcare, +1-978-659-4624, Web Site: http://www.philips.com/media

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

PHG Lyxor Index Fund-Lyxor Stoxx Europe 600 Pers& Hou Good UCITS ETF